Alliance Pharma plc Total Liabilities

Latest as of December 2024: GBX161.50 Million GBX ≈ $19.65K USD

Alliance Pharma plc total liabilities. Based on the latest financial reports, Alliance Pharma plc (APH) has total liabilities worth GBX161.50 Million GBX (≈ $19.65K USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Alliance Pharma plc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Alliance Pharma plc (1999–2024)

Total liabilities of Alliance Pharma plc from 1999 to 2024. This chart illustrates how Alliance Pharma plc's total liabilities have evolved over time, based on quarterly financial data. Explore Alliance Pharma plc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Alliance Pharma plc Competitors by Total Liabilities

The table below lists competitors of Alliance Pharma plc ranked by their total liabilities.

Company	Country	Total Liabilities
Critical Minerals Group Ltd AU:CMG	Australia	AU$3.78 Million
Sego Resources Inc V:SGZ	Canada	CA$470.19K
Modern Times Group Mtg AB ST:MTG-A	Sweden	Skr8.67 Billion
Ambica Agarbathies & Aroma industries Limited NSE:AMBICAAGAR	India	Rs1.32 Billion
One SA WAR:FMG	Poland	zł47.35 Million
Karma Energy Limited NSE:KARMAENG	India	Rs95.95 Million
Instituto Rosenbusch S.A. BA:ROSE	Argentina	AR$8.27 Billion
SINTEZA S.A. RO:STZ	Romania	RON13.16 Million

Liability Composition Analysis (1999–2024)

This chart breaks down Alliance Pharma plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Alliance Pharma plc assets under control.

Liquidity & Leverage Metrics

Alliance Pharma plc Total Liabilities Ratios Explained

Alliance Pharma plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.84	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alliance Pharma plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alliance Pharma plc (1999–2024)

The table below shows the annual total liabilities of Alliance Pharma plc from 1999 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX161.50 Million ≈ $19.65K	-18.04%
2023-12-31	GBX197.05 Million ≈ $23.98K	-21.10%
2022-12-31	GBX249.75 Million ≈ $30.39K	+13.01%
2021-12-31	GBX221.00 Million ≈ $26.89K	-3.02%
2020-12-31	GBX227.90 Million ≈ $27.73K	+70.76%
2019-12-31	GBX133.46 Million ≈ $16.24K	-11.86%
2018-12-31	GBX151.41 Million ≈ $18.42K	+13.76%
2017-12-31	GBX133.10 Million ≈ $16.19K	-5.92%
2016-12-31	GBX141.47 Million ≈ $17.21K	+9.03%
2015-12-31	GBX129.75 Million ≈ $15.79K	+249.85%
2014-12-31	GBX37.09 Million ≈ $4.51K	-12.37%
2013-12-31	GBX42.32 Million ≈ $5.15K	-13.23%
2012-12-31	GBX48.78 Million ≈ $5.93K	+27.83%
2011-12-31	GBX38.16 Million ≈ $4.64K	-7.65%
2010-12-31	GBX41.32 Million ≈ $5.03K	+2.86%
2009-12-31	GBX40.17 Million ≈ $4.89K	+0.26%
2008-12-31	GBX40.07 Million ≈ $4.87K	+0.82%
2007-12-31	GBX39.74 Million ≈ $4.84K	+5.59%
2006-12-31	GBX37.63 Million ≈ $4.58K	+33.19%
2005-12-31	GBX28.26 Million ≈ $3.44K	+2.86%
2005-02-28	GBX27.47 Million ≈ $3.34K	+13.45%
2004-02-29	GBX24.21 Million ≈ $2.95K	+15.26%
2003-02-28	GBX21.01 Million ≈ $2.56K	+87038.12%
2002-12-31	GBX24.11K ≈ $2.93	-99.71%
2002-02-28	GBX8.29 Million ≈ $1.01K	+144.28%
2001-02-28	GBX3.39 Million ≈ $412.71	-13.09%
2000-02-29	GBX3.90 Million ≈ $474.88	-39.53%
1999-02-28	GBX6.45 Million ≈ $785.27	--

About Alliance Pharma plc

LSE:APH UK Drug Manufacturers - Specialty & Generic

Market Cap

$4.26 Million

GBX34.97 Billion GBX

Market Cap Rank

#28808 Global

#513 in UK

Share Price

GBX64.70

Change (1 day)

+0.00%

52-Week Range

GBX64.70 - GBX64.70

All Time High

GBX116.47